Skip to main content

Nebulized salbutamol vs salbutamol and ipratropium combination in asthma

The Indian Journal of Pediatrics volume 71, pages 121–124 (2004)Cite this article

Abstract

Objective : To see the additional benefit of combined frequent nebulization with salbutamol and ipratropium bromide in acute attack of asthma with moderate severity.Methods : Fifty asthmatic children in the age range of 6–14 years were divided into two equal groups. Group I children were nebulized with three doses of Salbutamol alone (0.03 ml/kg/dose) and Group II children were given combined nebulization of Salbutamol (dose as in group I) and Ipratropium bromide (250 Μgm/dose for three doses) at 20 minutes interval. Children were observed at 15, 30, 60,120,180 and 240 minutes interval.Results : A significant improvement in % of PEFR starting at 30 minutes and lasting the entire study period of 4 hours was noted in both the groups. However on analysis of varience the results were better in group II.Conclusion : Frequent combined nebulization with Salbutamol and Ipratropium bromide is beneficial in acute asthma of moderate severity.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Schuh S, Parkin P, Rajan Aet al. High-versus low dose, frequently administered, nebulized albuterol in children with severe, acute asthma.Pediatrics 1989; 83: 513–518.

    PubMed  CAS  Google Scholar 

  2. Guidelines for the diagnosis and management of asthma: National Heart, Lung and Blood Institute, National Asthma Education Program. Expert Panel Report.J Allergy Clin Immunol 1991; 88: 425–534.

    Article  Google Scholar 

  3. Becker AB, Nelson NA, Sumons FER. Inhaled Salbutamol (albuterol) Vs injected epinephrine in the treatment of acute asthma in children.J Pediatr 1983; 102: 465–469.

    PubMed  Article  CAS  Google Scholar 

  4. Fischl MA, Pitchenik A, Gardner LB. An index predicting relapse and need for hospitalization in patients with acute bronchial asthma.N Engl J Med 1981; 305: 783–789.

    PubMed  CAS  Article  Google Scholar 

  5. Fanta CH, Rossing TH, McFadden ER Jr. Emergency room treatment of asthma. Relationship among therapeutic combinations, severity of obstruction and time course of response.Am J Med 1982; 72: 416–422.

    PubMed  Article  CAS  Google Scholar 

  6. Gandevia B. Historical view of the use of parasympatholytic agents in the treatment of respiratory disorders.Postgrad Med J 1975; 51(Suppl7): 13–20.

    PubMed  CAS  Google Scholar 

  7. Gross NJ, Skorodin MS. State of the art. Anticholinergic antimuscarinic bronchodilators.Am Rev Respir Dis 1984; 129: 856–870.

    PubMed  CAS  Google Scholar 

  8. Ullah MI, Newman GB, Saunders KB. Influence of age on response to ipratropium and salbutamol in asthma.Thorax 1981; 36: 523–529.

    PubMed  CAS  Google Scholar 

  9. Buhr W, Jones Jorres R, Berdel D, Landser FJ. Correspondence between forced oscillation andbody plethysmography during bronchoprovocation with carbachol in children.Pediatr Pulmonol 1990; 8: 280–288.

    PubMed  Article  CAS  Google Scholar 

  10. Warner JO, Naspitz CK. Third internation pediatric consensus statement on the management of childhood asthma.Pediatr Pulmonol 1998; 25: 1–17.

    PubMed  Article  CAS  Google Scholar 

  11. Plotnick L, Ducharme FM. Efficacy and safety of combined inhaled anticholinergics and beta-2 agonists in the initial management of acute pediatric asthma. In Cates C, Ducharme FM, Gibson P, Jones P, Rowe B, Wolf F, eds.Airways Module of the Cochrane Betabase of Systematic Reviews. The Cochrane Collaboration, Issue 2, Oxford’. Update Software: 1997.

  12. Rebuck AS, Chapman KR, Braude AC. Anticholinergic therapy of asthma.Chest 1982; 82 (1) (Suppl): 55S-57S.

    PubMed  Article  CAS  Google Scholar 

  13. Rebuck AS, Chapman KR, Abbound Ret al. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room.Am J Med 1987; 82: 59–64.

    PubMed  Article  CAS  Google Scholar 

  14. O’Driscole BF, Taylor RJ, Horsley M, Chambers DK, Bernstein A. Nebulized Salbutamol with and without ipratropium bromide in acute airflow obstruction.Lancet 1989; 1: 1418–1420.

    Article  Google Scholar 

  15. Higgins RM, Stradling RJ, Lane DM. Should ipratropium bromide be added to beta agonists in treatment of severe acute asthma?Chest 1988; 94: 718–722.

    PubMed  Article  CAS  Google Scholar 

  16. Warner JO, Naspitz CK. Third international pediatric consensus statement on the management of childhood asthma.Pediatr Pulmnol 1998; 25: 1–17.

    Article  CAS  Google Scholar 

  17. British Thoracic Societyet al. The British guidelines on asthma management: 1995 review and position statement.Thorax 1997; 52: S1-S22.

    Article  Google Scholar 

  18. Canadian Asthma Consensus Conference. Summary of recommendations.Can Respir J 1996; 3: 89–100.

    Google Scholar 

  19. International Pediatric Asthma Consensus group. Asthma: A follow up statement.Arch Dis Child 1992; 67: 240–248.

    Google Scholar 

  20. Parmar VR, Kumar L, Malik SK. Normal values of peak expiratory flow rate in healthy North Indian Children 6–16 years of age.Indian Pediatr 1977; 14: 591–4.

    PubMed  CAS  Google Scholar 

  21. Sly RM. Allergic Disorders. In Nelson WE, Beherman RE, Kliegman RM, Arvin AM, eds.Nelson Text Book of Pediatrics, 15th edn. Philadelphia WB Saunders Co., 1996; 610–656.

    Google Scholar 

  22. Warner JO, Gotz M, Landan LIet al. Management of asthma: A censensus Statement.Arch Dis Child 1989; 64: 1065–1079.

    PubMed  CAS  Google Scholar 

  23. Schuh S, Johnson DW, Callahan S, Canny G, Levison H. Efficacy of frequent nebulized ipratropium bromide added to frequent high dose albuterol therapy in severe childhood asthma.J Pediatr 1995; 126: 639–645.

    PubMed  Article  CAS  Google Scholar 

  24. Reisman J, Galdes-Sebalt M, Kazim F, Canny G, Levison H. Frequent administration by inhalation of Salbutamol and ipratropium bromide in the initial management of severe acute asthma in children.J Allergy Clin Immunol 1988; 81(1): 16–20.

    PubMed  Article  CAS  Google Scholar 

  25. Lenney W, Evans NAP. Nebulized salbutamol and ipratropium bromide in asthmatic children.Br J Dis Chest 1986; 80: 59–65.

    PubMed  Article  CAS  Google Scholar 

  26. Ruffin RE, Fitzgerald JD, Revuck AS. A comparison of the bronchodilator activity of Sch 1000 and Salbutamol.J Allerg Clin Immunol 1977; 59: 136–141.

    Article  CAS  Google Scholar 

  27. Lightbody IM, Ingram CG, Legge JS, Johnston RN. Ipratropium bromide, Salbutamol and prednisolone in bronchial asthma and chronic bronchitis.Br J Dis Chest 1978; 72: 181–186.

    PubMed  Article  CAS  Google Scholar 

  28. Ducharme FM, Davis GM. Randomized controlled trial of ipratropium bromide and frequent low doses of Salbutamol in the management of mild and moderate acute pediatric asthma.J Pediatr 1998; 133: 479–485.

    PubMed  Article  CAS  Google Scholar 

  29. Guill MF, Maloney MJ, DuRant RH. Comparison of inhaled metaproterenol, inhaled atropine sulphate, and their combination in the treatment of children with acute asthma.Ann Allerg 1987; 59: 367–71.

    PubMed  CAS  Google Scholar 

  30. Beck R, Robertson C, Galdes-Sebaldt M, Levison H. Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma.J Pediatr 1985; 107(4): 605–608.

    PubMed  Article  CAS  Google Scholar 

  31. Storms WW, Dopico GA, Reed CE. Aerosol sch 1000: an anticholinergic brochodilator.Am Rev Respir Dis 1975; 111: 419.

    PubMed  CAS  Google Scholar 

  32. De Troyer A, Yernault JC, Rodenstein D. Effect of vagal blockade on lung mechanics in normal man.J Appl Physiol 1979; 46: 217–226.

    PubMed  Google Scholar 

  33. Ingram RH, Wellman JJ, McFadden ER, Mead J. Relative contributions of large andsmall airways to flow limitation in normal subjects before and after atropineand isoproterenol.J Clin Invest 1977; 59: 696–703.

    PubMed  CAS  Google Scholar 

  34. Hensley MJ, O’Cain CF, McFadden ER, Ingram RH. Distribution of bronchodilatation in normal subjects: beta agonist versus atropine.J Appl Physiol 1978; 45: 778–782.

    PubMed  CAS  Google Scholar 

  35. Cookson DU, Reed CE. A comparison of the effects of isoproterenol in the normal and asthmatic subject.Am Rev Respir Dis 1963; 88: 636–643.

    PubMed  CAS  Google Scholar 

  36. Chervinsky P. Double blind study of ipratropium bromide, a new anticholinergic bronchodilator.J Allergy Clin Immunol 1977; 59(1): 22–30.

    PubMed  Article  CAS  Google Scholar 

  37. Clark PS, Jarrett RG, Hall GJL. The protective effect of ipratropium bromide aerosol against bronchospasm induced by hyperventilation and the inhalation of allergen, methacholine and histamine.Ann Allergy 1982; 48: 180–182.

    Google Scholar 

  38. Ward MJ, MacFarlane JT, Davies D. Treatment of acute severe asthma with intravenous aminophylline and nebulized ipratropium bromide after Salbutamol (abstr).Thorax 1982; 37: 785.

    Google Scholar 

  39. Summers QA, Tarala RA. Neubilized ipratropium in the treatment of acute asthma.Chest 1990; 97: 430–434.

    Article  Google Scholar 

  40. Milner AD. Bronchodilator drugs in childhood asthma.Arch Dis Child 1981; 56: 84–85.

    PubMed  CAS  Article  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Pediatrics, Pt. B.D.Sharma Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India

    Anita Sharma & Arvind Madaan

Authors
  1. Anita Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arvind Madaan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anita Sharma.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sharma, A., Madaan, A. Nebulized salbutamol vs salbutamol and ipratropium combination in asthma. Indian J Pediatr 71, 121–124 (2004). https://doi.org/10.1007/BF02723090

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02723090

Key words

  • Bronchial asthma
  • Acute exacerbation
  • Nebulized Salbutamol
  • Ipratropium bromide
  • Salbutamol combination